Adenocarcinoma: all 1,996 studies
Page 17 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early AdenocarcinomaCompletedNCT01961778Not applicable
- Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal CancerStatus unknownNCT01952951Phase 2
- A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of RelapseActive, not recruitingNCT01952223Phase 3
- Treatment of Multifocal Lung AdenocarcinomaTerminatedNCT01946100Not applicable
- Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and PancreasStatus unknownNCT01942629
- A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.Status unknownNCT01941979Phase 3
- Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT01935973Phase 1
- Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal AdenocarcinomaCompletedNCT01932580Phase 2
- Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)CompletedNCT01929616Phase 2
- Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic CancerCompletedNCT01924260Phase 1
- Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal CancerCompletedNCT01923337Phase 1
- Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20)CompletedNCT01900717Phase 2
- Cryotherapy -BEATS-RF Ablation TrialCompletedNCT01882478
- Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric AdenocarcinomaStatus unknownNCT01880632Phase 2
- Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]Status unknownNCT01879878Not applicable
- ESD Versus EMR for Treatment of Early Barrett's AdenocarcinomaCompletedNCT01871636Not applicable
- CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung CancerTerminatedNCT01871480Phase 2
- Assisted Exercise in Obese Endometrial Cancer PatientsCompletedNCT01870947Not applicable
- A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients With Barrett's Dysplasia or Intramucosal AdenocarcinomaCompletedNCT01862666
- Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWithdrawnNCT01859182Phase 2
- A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With AbirateroneCompletedNCT01857908
- Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung AdenocarcinomaCompletedNCT01851096Phase 1
- CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01839981Phase 1
- CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT01835041Phase 1
- EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic CancerCompletedNCT01834170Phase 1
- Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic CancerWithdrawnNCT01830322Phase 2
- AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the LungCompletedNCT01827852
- ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerCompletedNCT01825603Phase 1
- Signet Ring Cell Carcinoma in Esophageal AdenocarcinomaCompletedNCT01824966
- S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsCompletedNCT01824459Phase 3
- Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerCompletedNCT01821612Early Phase 1
- Density of Neurons in the Stomach and Prognosis of Gastric AdenocarcinomaWithdrawnNCT01821196Not applicable
- NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung AdenocarcinomaTerminatedNCT01819428Phase 2
- XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of StomachStatus unknownNCT01798251Phase 2
- Active Surveillance of 2 Groups of Patients With Localized Prostate CancerTerminatedNCT01795365Not applicable
- Diffusion Weighted Magnetic Resonance Imaging for Preoperative Staging in Gastric Adenocarcinoma PatientsCompletedNCT01794026Early Phase 1
- Prevalence of Dysplasia of the Gastric CardiaCompletedNCT01787864
- Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction CancerStatus unknownNCT01786278Phase 2/3
- Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following SurgeryCompletedNCT01780220Phase 1/2
- Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)CompletedNCT01778920Phase 1
- Molecular Epidemiology of Lung Adenocarcinoma in Multi-ethnic Asian PhenotypeStatus unknownNCT01774526Not applicable
- Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic CancerCompletedNCT01770132Phase 1
- Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid TumorsCompletedNCT01765790Phase 1
- Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic AdenocarcinomaCompletedNCT01765036Not applicable
- Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT01764477Phase 1
- Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma ProtocolTerminatedNCT01760252Phase 2
- Spectroscopy From DuodenumCompletedNCT01753479Not applicable
- Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary AdenocarcinomaStatus unknownNCT01745302
- Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or LungWithdrawnNCT01741597Phase 1
- Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryTerminatedNCT01739439Phase 1
- Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate CancerTerminatedNCT01737151Not applicable
- A Phase I-II Study of PAXG in Stage III-IV Pancreatic AdenocarcinomaCompletedNCT01730222Phase 1/2
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
- Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareCompletedNCT01726296Not applicable
- Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in AdenocarcinomasSuspendedNCT01723306Phase 2
- Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma PatientsCompletedNCT01719536Phase 3
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic CancerCompletedNCT01715142Early Phase 1
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic CancerStatus unknownNCT01713218Early Phase 1
- Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerTerminatedNCT01707823Early Phase 1
- Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the TherapeuticCompletedNCT01703910Phase 2
- Role of Perfusion CT in Pancreatic CancerStatus unknownNCT01703650
- Extralevator Versus Standard Abdominoperineal Resection For Rectal AdenocarcinomaStatus unknownNCT01702116Not applicable
- Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric JunctionStatus unknownNCT01697917Phase 3
- First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaTerminatedNCT01697072Phase 3
- Improving the Treatment for Women With Early Stage Cancer of the UterusActive, not recruitingNCT01686126Phase 2
- TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate CancerStatus unknownNCT01682772Phase 2
- A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic AdenocarcinomaCompletedNCT01677962Phase 1
- A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT01676259Phase 2
- Ultrasound-assisted Treatment of Inoperable Pancreatic CancerCompletedNCT01674556Phase 1
- Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric AdenocarcinomaCompletedNCT01672333Phase 2
- Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric CancerCompletedNCT01671774Phase 1
- Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung AdenocarcinomaStatus unknownNCT01665417Phase 4
- Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing SurgeryCompletedNCT01646697Not applicable
- Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer PatientsStatus unknownNCT01641783Phase 2
- Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the StomachCompletedNCT01640782Phase 3
- Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local ApplicationCompletedNCT01639625Phase 2
- Nodal Status in Adenocarcinoma of the Esophagus an CardiaCompletedNCT01635595
- A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal AdenocarcinomaCompletedNCT01634685Phase 1
- Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerCompletedNCT01630083Phase 2
- Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal AdenocarcinomasTerminatedNCT01619696Phase 2
- Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIWithdrawnNCT01605344Phase 1
- Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain MetastasisCompletedNCT01603849Not applicable
- OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the PancreasWithdrawnNCT01600807Phase 1/2
- Mutation Analysis and Copy Number Changes of KRAS and BRAF Gene in Taiwanese Cases of Biliary Tact AdenocarcinomaStatus unknownNCT01588860
- Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung AdenocarcinomaCompletedNCT01588704Phase 2
- SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric CancerStatus unknownNCT01583361Phase 3
- Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesCompletedNCT01578668Phase 2
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric CancerCompletedNCT01567618Phase 2
- NESC: Neoadjuvant Treatment of Gastric AdenocarcinomaCompletedNCT01565109Phase 2
- The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With EndostarStatus unknownNCT01564329Phase 2
- A Study of MEK162 and AMG 479 in Patients With Selected Solid TumorsTerminatedNCT01562899Phase 1/2
- Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the LungCompletedNCT01561456Phase 2
- Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
- Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic AdenocarcinomaCompletedNCT01558869Phase 2
- Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma StudyTerminatedNCT01558011Phase 2
- Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer PatientsCompletedNCT01554059Phase 2
- Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric AdenocarcinomaStatus unknownNCT01552980Phase 2
- Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal AdenocarcinomaStatus unknownNCT01552967Phase 2
- Second Line Chemotherapy for Advanced Pancreatic CancerCompletedNCT01543412Phase 2